Fiona Rutherford's profile photo

Fiona Rutherford

New York

U.S. Healthcare Reporter at Bloomberg News

Bloomberg News Reporter / [email protected]

Featured in: Favicon bloomberg.com Favicon medium.com Favicon msn.com Favicon globo.com Favicon washingtonpost.com Favicon time.com Favicon yahoo.com (+7) Favicon buzzfeed.com Favicon ft.com Favicon latimes.com

Articles

  • 2 weeks ago | infobae.com | Fiona Rutherford

    Un científico de Harvard especializado en adicciones y un exabogado del Gobierno instan al Departamento de Justicia de Estados Unidos a rechazar un plan que suavizaría las restricciones federales sobre el cannabis, con el que el sector ha contado para hacer crecer sus negocios.

  • 2 weeks ago | bostonglobe.com | Fiona Rutherford

    A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses. In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration’s push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.

  • 2 weeks ago | news.bloombergtax.com | Fiona Rutherford

    XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

  • 2 weeks ago | news.bloomberglaw.com | Fiona Rutherford

    A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses. In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration’s push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.

  • 2 weeks ago | bloomberg.com | Fiona Rutherford

    Rescheduling would move cannabis into a lower-risk category, recognizing its potential medical use. (Bloomberg) -- A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
7K
Tweets
6K
DMs Open
Yes
Fiona Rutherford
Fiona Rutherford @Fi_Rutherford
24 Apr 25

RT @ZSchneeweiss: Europeans saw Trump’s trade war coming and gorged on US booze https://t.co/09Hheyqn5i via @Fi_Rutherford https://t.co/BSz…

Fiona Rutherford
Fiona Rutherford @Fi_Rutherford
17 Apr 25

RT @MikeDorning: How Trump's policies are hurting beer sales. @Fi_Rutherford @sabahmeddings via @economics Gift Link: https://t.co/7kbeYLz…

Fiona Rutherford
Fiona Rutherford @Fi_Rutherford
13 Mar 25

RT @ZSchneeweiss: US whiskey makers look to flood EU market ahead of 50% tariffs https://t.co/xf5telicGJ via @Fi_Rutherford https://t.co/kO…